|
1
|
De Boer Posthuma J, Witlox MA, Kaspers GJ
and van Royen BJ: Molecular alterations as target for therapy in
metastatic osteosarcoma: a review of literature. Clin Exp
Metastasis. 28:493–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang W, Gao B, Fu P, Xu S, Qian Y and Fu
Q: The miRNAs in the pathogenesis of osteosarcoma. Front Biosci
(Landmark Ed). 18:788–794. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tatsumoto T, Xie X, Blumenthal R, Okamoto
I and Miki T: Human ECT2 is an exchange factor for rho GTpases,
phosphorylated in G2/M phases and involved in cytokinesis. J Cell
Biol. 147:921–928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salhia B, Tran NL, Chan A, et al: The
guanine nucleotide exchange factors trio, Ect2 and Vav3 mediate the
invasive behavior of glioblastoma. Am J Pathol. 173:1828–1838.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miki T, Smith CL, Long JE, Eva A and
Fleming TP: Oncogene ect2 is related to regulators of small
GTP-binding proteins. Nature. 362:462–465. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fields AP and Justilien V: The guanine
nucleotide exchange factor (GEF) Ect2 is an oncogene in human
cancer. Adv Enzyme Regul. 50:190–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murata Y, Minami Y, Iwakawa R, et al: ECT2
amplification and overexpression as a new prognostic biomarker for
early-stage lung adenocarcinoma. Cancer Sci. 105:490–497. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu J, Yao Q, Hou Y, et al:
Mir-223/ect2/p21 signaling regulates osteosarcoma cell cycle
progression and proliferation. Biomed Pharmacother. 67:381–386.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Yin Z, Ning K, Wang L, Guo R and
Ji Z: Prognostic value of microRNA-223/epithelial cell transforming
sequence 2 signaling in patients with osteosarcoma. Hum Pathol.
45:1430–1436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang YL, Chu JY, Luo ML, et al:
Amplification of PRKCI, located in 3q26, is associated with lymph
node metastasis in esophageal squamous cell carcinoma. Genes
Chromosomes Cancer. 47:127–136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hussenet T, Dali S, Exinger J, et al: SOX2
is an oncogene activated by recurrent 3q26.3 amplifications in
human lung squamous cell carcinomas. PLoS One. 5:e89602010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Hill KS and Fields AP: PKCiota
maintains a tumor-initiating cell phenotype that is required for
ovarian tumorigenesis. Mol Cancer Res. 11:1624–1635. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nalini V, Segu R, Deepa PR, Khetan V,
Vasudevan M and Krishnakumar S: Molecular insights on
post-chemotherapy retinoblastoma by microarray gene expression
analysis. Bioinform Biol Insights. 7:289–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Samuel N, Sayad A, Wilson G, et al:
Integrated genomic, transcriptomic and RNA-interference analysis of
genes in somatic copy number gains in pancreatic ductal
adenocarcinoma. Pancreas. 42:1016–1026. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vazquez-Mena O, Medina-Martinez I,
Juarez-Torres E, et al: Amplified genes may be overexpressed,
unchanged, or downregulated in cervical cancer cell lines. PLoS
One. 7:e326672012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jung Y, Lee S, Choi HS, et al: Clinical
validation of colorectal cancer biomarkers identified from
bioinformatics analysis of public expression data. Clin Cancer Res.
17:700–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iyoda M, Kasamatsu A, Ishigami T, et al:
Epithelial cell transforming sequence 2 in human oral cancer. PLoS
One. 5:e140822010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boettner B and Van Aelst L: The role of
rho GT pases in disease development. Gene. 286:155–174. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fortin SP, Ennis MJ, Schumacher CA, et al:
Cdc42 and the guanine nucleotide exchange factors ect2 and trio
mediate fn14-induced migration and invasion of glioblastoma cells.
Mol Cancer Res. 10:958–968. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sano M, Genkai N, Yajima N, et al:
Expression level of ECT2 proto-oncogene correlates with prognosis
in glioma patients. Oncol Rep. 16:1093–1098. 2006.PubMed/NCBI
|
|
22
|
Justilien V, Jameison L, Der CJ, Rossman
KL and Fields AP: Oncogenic activity of Ect2 is regulated through
protein kinase C iota-mediated phosphorylation. J Biol Chem.
286:8149–8157. 2011. View Article : Google Scholar : PubMed/NCBI
|
